Venous Thromboembolism
Aspirin was found to be safe and effective in patients with a wide range of VTE risk who underwent total knee arthroplasty.
Efficacy appeared to be similar among DOACs for managing cancer-related VTE, though apixaban may have more favorable safety.
Patients with RA had a 57% increased risk of VTE; a 58% increased risk of DVT; and a 57% increased risk of PE.
Tranexamic acid did not seem to increase risk of postoperative complications in patients undergoing total joint arthroplasty.
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
MPN-associated vascular thromboembolisms were more common in JAK2-mutated diseases and less common in CALR-mutated diseases.
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH.
Patients with severe LMWH are less likely to experience VTE.
In the 30-day period following consultation or hospitalization for gout flares, a transient increase in the rate of ...
Advertisement
Expert Interviews on Hematology
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.